NL-OMON45061已完成不适用
Towards individual medicine in ADHD: A pilot study on using individual differences in neural reward sensitivity to predict the efficacy of a behavioral intervention in ADHD (The SCORE! study). - The SCORE! study.
niversitair Medisch Centrum Utrecht0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17(—)
入选标准
- •Inclusion criteria for patients (children with ADHD):
- •1. Age between 8;6 (8 years and 6 months) and 12;11 (12 years and 11 months).
- •2. A clinical diagnosis of ADHD (comorbidities are allowed in order to more closely reflect the typical clinical population), that is confirmed using the Disruptive Behavior Disorders Module (Module E) of the Diagnostic Interview Schedule for Children (DISC) (Schaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000).
排除标准
- •1. Estimated IQ < 80, since cognitive behavioral treatments are generally not indicated in this IQ range.
- •2. A known (congenital) cardiovascular disease, since this may influence the ECG and subsequent analyses.
- •3. History of or present neurological disorder. A neurological disorder is defined as any disorder that requires care from a neurologist.
研究者
相似试验
招募中
不适用
Treatment of ADHD with care as usual versus an elimination dietEnglish:ADHD, attention deficit and hyperactivity disorders, diet intervention, elimination diet, Dutch:ADHD, aandachtstekortstoornis met hyperactiviteit, dieetinterventie, eliminatie dieetNL-OMON25997Karakter, kinder- en jeugdpsychiatrie230
招募中
不适用
Clinical record investigation about ADHD children before and after the emergency declaration because of COVID19Attention-Deficit/Hyperactivity Disorder: AD/HDJPRN-UMIN000040476Chiba University10
已完成
不适用
A Novel Device for the Management of ADHDADHDNCT05777785VIZO Specs Ltd108
招募中
不适用
Treatment of ADHD with Care as usual versus an Elimination diet: An exploratory investigation on the biological mechanisms underlying the effects of an elimination diet treatment in ADHDADHDattention-deficit/hyperactivity disorder10009841NL-OMON42519CNS301
已完成
4 期
Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHDAttention Deficit Hyperactivity DisorderNCT00485875Eli Lilly and Company62
